MSD Pharmaceuticals launches gender-neutral HPV vaccine GARDASIL 9 in India
"Launching GARDASIL 9 is a crucial step towards advancing the mission of building a healthy young India by reducing the disease burden of HPV-related cancers and disease in the country," MSD India Region Managing Director Rehan A Khan said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 29, 2021 Category: Pharmaceuticals Source Type: news
Quickstats: Percentage of Adults Aged 18-26 Years Who Ever Received a Human Papillomavirus Vaccine, by Race and Hispanic Origin and Sex - National Health Interview Survey, United States, 2019
This report describes the percentage of adults aged 18-26 years who received a human papillomavirus vaccine, by race and Hispanic origin and sex. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - May 27, 2021 Category: American Health Tags: Adult Vaccinations HPV Infection (Human Papillomavirus) HPV Vaccination (Human Papillomavirus) MMWR Morbidity & Mortality Weekly Report Source Type: news
HPV vaccine has led to more than 80% drop in infections, CDC reports
Introduction of the human papillomavirus vaccine in the United States has led to a more than 80% decline in infections nationally since 2003, according to data released Thursday by the CDC. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 25, 2021 Category: Consumer Health News Source Type: news
Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018
This report describes declines in HPV vaccine-type infection prevalence among females when compared with prevalence before vaccination. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - March 25, 2021 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
We All Deserve Protection From Covid-19
Credit: United NationsBy Adaora OkoliNEW ORLEANS, US, Dec 11 2020 (IPS) When I contracted Ebola virus disease in August 2014 while working as a medical doctor in a well-known private hospital in Lagos, Nigeria, I was denied access to a potential cure.
For 15 days, I battled for my life in a debilitated isolation ward, not knowing if I would survive. But American aid workers who contracted Ebola were administered Zmapp, a monoclonal antibody treatment, which reduces the relative risk of death from Ebola by 40% as well as shorten the duration of stay in the Ebola treatment units. They survived.
We were told that Zmapp was e...
Source: IPS Inter Press Service - Health - December 11, 2020 Category: International Medicine & Public Health Authors: Adaora Okoli Tags: Headlines Health TerraViva United Nations Source Type: news
School HPV vaccine policies could result in higher vaccination rates, reduction in cancers
FINDINGSA UCLA-led study has found that in 2 of 3 states and jurisdictions with policies that require students entering school to receive the human papillomavirus vaccine, vaccination rates among 13-to-17-year-olds were significantly higher than in surrounding states without such policies.In Rhode Island, the vaccination rate among adolescents was 91%, compared with an average of 78% in neighboring non-policy states. In the District of Columbia, the rate was 89%, compared with 72% for nearby non-policy states. Virginia, which is in the same region as the district, was the one state with a vaccination policy that showed no ...
Source: UCLA Newsroom: Health Sciences - June 29, 2020 Category: Universities & Medical Training Source Type: news
FDA Approves HPV Vaccine Gardasil As Throat Cancer Prevention
The HPV vaccine (Gardasil 9) has been approved by the Food and Drug Administration (FDA) for males and females ages 9 to 45 years to prevent HPV-related genital tract and anogenital infections and cancers for several years. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 17, 2020 Category: Pharmaceuticals Authors: Nina Shapiro, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news
Gardasil-9 Approved for Prevention of Head and Neck Cancers Gardasil-9 Approved for Prevention of Head and Neck Cancers
The FDA has expanded the indication for the Gardasil-9 vaccine to include the prevention of head and neck cancersMedscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 15, 2020 Category: Primary Care Tags: Hematology-Oncology News Source Type: news
FDA Approves Merck ’s Gardasil 9 for the Prevention of Certain HPV-Related Head and Neck Cancers
KENILWORTH, N.J.--(BUSINESS WIRE) June 12, 2020 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Gardasil 9 for the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 15, 2020 Category: Drugs & Pharmacology Source Type: news
Exploring Opportunities to Leverage Pharmacists in Rural Areas to Promote Administration of Human Papillomavirus Vaccine
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - March 12, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news
The Damage of Vaccine Misinformation
From 2013 to 2016, negative information about the HPV (human papillomavirus) vaccine spread widely through Danish media outlets. As a result, thousands of girls did not receive the vaccine. (Source: WebMD Health)
Source: WebMD Health - January 23, 2020 Category: Consumer Health News Source Type: news
The Damage of Vaccine Misinformation
THURSDAY, Jan. 23, 2020 -- An examination of vaccination trends in Denmark shows just how damaging vaccine misinformation can be.
From 2013 to 2016, negative information about the HPV (human papillomavirus) vaccine spread widely through Danish... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 23, 2020 Category: General Medicine Source Type: news
Doubts raised about effectiveness of HPV vaccines
(SAGE) A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness. The analysis, published by the Journal of the Royal Society of Medicine, assessed 12 published Phase 2 and 3 randomized controlled efficacy trials of the HPV vaccines Cervarix and Gardasil. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 21, 2020 Category: Cancer & Oncology Source Type: news
Studies Confirm HPV Shot Is Safe
New studies included millions of doses of Gardasil 9 vaccine, the only vaccine currently used in the United States for the prevention of HPV-related cancers. (Source: WebMD Health)
Source: WebMD Health - November 18, 2019 Category: Consumer Health News Source Type: news
Studies Confirm Safety of 9-Valent HPV Vaccination
MONDAY, Nov. 18, 2019 -- The safety of the 9-valent human papillomavirus vaccine (9vHPV) has been confirmed, according to two studies published online Nov. 18 in Pediatrics.
Tom T. Shimabukuro, M.D., M.P.H., from the U.S. Centers for Disease Control... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2019 Category: Pharmaceuticals Source Type: news
